pubrio
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. logo

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.

Public
3healthcare.com
リサーチ2,200+ employeesFounded 2007🇨🇳 中国

Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.

設立年
2007
従業員数
2,200+
業種
リサーチ
企業タイプ
Public Company
株式
shh: 688366.SS
本社
🇨🇳4f, No 2 Building, Alley 139, Shanghai, China (+1)
専門分野
リサーチ

拡大インテリジェンス

NEW · Pubrio 限定

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. の市場拡大を追跡しています

グローバル展開

ライブ
ステージ
検討中投資中参入中稼働中
知っておきたい情報

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. に関するよくある質問

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. の事業、市場、成長シグナルに関する簡潔な回答。

Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.

今日から旅を始めましょう

まずはプラットフォームでも、まずは会話からでも

Pubrio を自分で使うことも、リサーチ・リード獲得・データ連携を私たちに任せることもできます。

チームに相談
Start Journey Image
pubrio

Pubrio は 50 以上のローカルソースからビジネス・人物・インテントデータを統合し、AI と収益チームに市場全体の可視性を提供します。

© 2026 Pubrio. 無断転載を禁じます。